Genmab — Juni 2020

[E_L]

I posted this seekingalpha article a while ago, as it also looked at cervical cancer https://seekingalpha.com/article/4335715-agenus-time-of-coronavirus

[Bulder]

Yes I was quite surprised on European numbers. What countries are they that bring the numbers so high?

[E_L]

don't know, good question. I know in the netherlands it is only 200 -250, we have large cervical cancer screening programmes

[E_L]

HPV Vaccination here is around 70% i believe, by chance it was in the newspaper that this year it went up by 7%

[E_L]

this morning

[nohope]

When will it be available for commercial use ? In 5-10 years ? At that time we hopefully(!) will see a sharp decline in cervical cancer due to vaccine.

[GeorgeBest]

Tiso will be available next year in 2nd line and onwards

[GeorgeBest]

In US at least

[nohope]

Ok. Let´s hope that it will be of benefit to both the women - and us.

[E_L]

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Genmab (NASDAQ:GMAB) A/S on Tuesday, setting a price target of $40,

[E_L]

i actually thought they were already at $40

[Monforte]

@EL, you are right , see EL 11/6

[kkjoel]

They were. "He REITERATED a buy rating.." and apparently the same goes for the target (setting)...

[bikube]

ATH i U S 33,53 = 2229 Dkk

[E_L]

Seattle Genetics (SGEN) PT Raised to $210 at Oppenheimer on Positive Ph2 Tisotumab Vedotin (TV) Study

[Sukkeralf]

from what?

[E_L]

(from $200.00. They have 173.1M shares outstanding, so a $10 raise means $1.731bn in value

[bikube]

S Gen´s kurs i aftes 164,37

[E_L]

that would be almost dkk180 on Genmab? that seems a bit excessive?

[E_L]

@bikube yes, but that is not relevant in this calculation